These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 10861039)

  • 1. Positive impact of inhibitory Ly49 receptor-MHC class I interaction on NK cell development.
    Lowin-Kropf B; Held W
    J Immunol; 2000 Jul; 165(1):91-5. PubMed ID: 10861039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positive recognition of MHC class I molecules by the Ly49D receptor of murine NK cells.
    George TC; Mason LH; Ortaldo JR; Kumar V; Bennett M
    J Immunol; 1999 Feb; 162(4):2035-43. PubMed ID: 9973475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A role for the src family kinase Fyn in NK cell activation and the formation of the repertoire of Ly49 receptors.
    Lowin-Kropf B; Kunz B; Schneider P; Held W
    Eur J Immunol; 2002 Mar; 32(3):773-82. PubMed ID: 11870621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MHC class I-Ly49 interactions shape the Ly49 repertoire on murine NK cells.
    Fahlén L; Lendahl U; Sentman CL
    J Immunol; 2001 Jun; 166(11):6585-92. PubMed ID: 11359811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cumulative inhibition of NK cells and T cells resulting from engagement of multiple inhibitory Ly49 receptors.
    Hanke T; Raulet DH
    J Immunol; 2001 Mar; 166(5):3002-7. PubMed ID: 11207249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levels of Ly-49 receptor expression are determined by the frequency of interactions with MHC ligands: evidence against receptor calibration to a "useful" level.
    Manilay JO; Waneck GL; Sykes M
    J Immunol; 1999 Sep; 163(5):2628-33. PubMed ID: 10453002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiation of NK1.1+, Ly49+ NK cells from flt3+ multipotent marrow progenitor cells.
    Williams NS; Klem J; Puzanov IJ; Sivakumar PV; Bennett M; Kumar V
    J Immunol; 1999 Sep; 163(5):2648-56. PubMed ID: 10453005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Orderly and nonstochastic acquisition of CD94/NKG2 receptors by developing NK cells derived from embryonic stem cells in vitro.
    Lian RH; Maeda M; Lohwasser S; Delcommenne M; Nakano T; Vance RE; Raulet DH; Takei F
    J Immunol; 2002 May; 168(10):4980-7. PubMed ID: 11994449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tolerance and alloreactivity of the Ly49D subset of murine NK cells.
    George TC; Ortaldo JR; Lemieux S; Kumar V; Bennett M
    J Immunol; 1999 Aug; 163(4):1859-67. PubMed ID: 10438920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural killing of MHC class I(-) lymphoblasts by NK cells from long-term bone marrow culture requires effector cell expression of Ly49 receptors.
    Lindberg J; Martín-Fontecha A; Höglund P
    Int Immunol; 1999 Aug; 11(8):1239-46. PubMed ID: 10421781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct assessment of MHC class I binding by seven Ly49 inhibitory NK cell receptors.
    Hanke T; Takizawa H; McMahon CW; Busch DH; Pamer EG; Miller JD; Altman JD; Liu Y; Cado D; Lemonnier FA; Bjorkman PJ; Raulet DH
    Immunity; 1999 Jul; 11(1):67-77. PubMed ID: 10435580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Class I MHC-binding characteristics of the 129/J Ly49 repertoire.
    Makrigiannis AP; Pau AT; Saleh A; Winkler-Pickett R; Ortaldo JR; Anderson SK
    J Immunol; 2001 Apr; 166(8):5034-43. PubMed ID: 11290784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clonal analysis of NK cell development from bone marrow progenitors in vitro: orderly acquisition of receptor gene expression.
    Williams NS; Kubota A; Bennett M; Kumar V; Takei F
    Eur J Immunol; 2000 Jul; 30(7):2074-82. PubMed ID: 10940897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered phenotype and function of natural killer cells expressing the major histocompatibility complex receptor Ly-49 in mice transgenic for its ligand.
    Olsson MY; Kärre K; Sentman CL
    Proc Natl Acad Sci U S A; 1995 Feb; 92(5):1649-53. PubMed ID: 7878033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered expression of Ly49 inhibitory receptors on natural killer cells from MHC class I-deficient mice.
    Salcedo M; Diehl AD; Olsson-Alheim MY; Sundbäck J; Van Kaer L; Kärre K; Ljunggren HG
    J Immunol; 1997 Apr; 158(7):3174-80. PubMed ID: 9120271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutting edge: dominance by an MHC-independent inhibitory receptor compromises NK killing of complex targets.
    Wahle JA; Paraiso KH; Costello AL; Goll EL; Sentman CL; Kerr WG
    J Immunol; 2006 Jun; 176(12):7165-9. PubMed ID: 16751359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The MHC class I molecule H-2Dp inhibits murine NK cells via the inhibitory receptor Ly49A.
    Olsson-Alheim MY; Sundbäck J; Kärre K; Sentman CL
    J Immunol; 1999 Jun; 162(12):7010-4. PubMed ID: 10358142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. External and internal calibration of the MHC class I-specific receptor Ly49A on murine natural killer cells.
    Kåse A; Johansson MH; Olsson-Alheim MY; Kärre K; Höglund P
    J Immunol; 1998 Dec; 161(11):6133-8. PubMed ID: 9834098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired natural killing of MHC class I-deficient targets by NK cells expressing a catalytically inactive form of SHP-1.
    Lowin-Kropf B; Kunz B; Beermann F; Held W
    J Immunol; 2000 Aug; 165(3):1314-21. PubMed ID: 10903732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ly-49s3 is a promiscuous activating rat NK cell receptor for nonclassical MHC class I-encoded target ligands.
    Naper C; Hayashi S; Kveberg L; Niemi EC; Lanier LL; Vaage JT; Ryan JC
    J Immunol; 2002 Jul; 169(1):22-30. PubMed ID: 12077224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.